Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison

Pediatric Hematology and Oncology
Funda CorapçioğluEmine Zengin

Abstract

The purpose of this study was to compare the efficacy, safety, and cost of piperacillin/tazobactam with cefepime monotherapy in children with febrile neutropenia. A prospective randomized study in children and adolescent with cancer was conducted. Patients were randomly assigned to receive either 80 mg/kg piperacillin/10 mg/kg tazobactam every 6 h (maximum 4.5 g/dose) or cefepime 50 mg/kg every 8 h (maximum 2 g/dose). Treatment modification was defined as all the changes in the empirical antimicrobials after the first 96 h. Overall treatment success was defined as cure of febrile episode with or without modification. Cost of hospitalization, antimicrobial drugs, and supportive therapy were calculated. Fifty febrile neutropenic episodes (25 in the piperacillin/tazobactam group, 25 in the cefepime group) in 27 pediatric cancer patients were evaluated. The groups were comparable in terms of age, gender, body weight, primary diagnosis, disease status, initial neutrophil count, and duration of neutropenia. Microbiologically and clinically documented infection rate was 46%. There was no infection-related mortality in the study period. The treatment success of initial empirical therapy without modification was not different in the 2 g...Continue Reading

References

Dec 1, 1994·Antimicrobial Agents and Chemotherapy·M D ReedJ L Blumer
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Klastersky
Aug 8, 1998·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·U HessH J Senn
Dec 2, 1998·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·E CastagnolaC Viscoli
Oct 26, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R Ramphal
Aug 11, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·G FleischhackU Bode
Sep 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A Del FaveroUNKNOWN Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Apr 12, 2003·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M GorschlüterA Glasmacher
Jul 29, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A ComettaUNKNOWN International Antimicrobial Therapy Group of the European Organization for Research Treatment of Cancer
May 13, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·N Le GuyaderG Leverger

❮ Previous
Next ❯

Citations

Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Feb 25, 2009·Expert Opinion on Drug Metabolism & Toxicology·Maria F Wolf, Arne Simon
Jul 11, 2008·Expert Opinion on Drug Safety·Lorenzo Drago, Elena De Vecchi
Nov 17, 2009·Infectious Disease Clinics of North America·Susana Chavez-Bueno, Terrence L Stull
Jun 25, 2009·Seminars in Hematology·L Charles BaileySusan R Rheingold
Mar 10, 2007·International Journal of Antimicrobial Agents·Abhijit M Bal, Ian M Gould
Sep 12, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Sema VuralRejin Kebudi
Jun 28, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Gulay SezginAtila Tanyeli
Jul 5, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuo TamuraMasahiro Saito
Feb 7, 2014·Pediatric Hematology and Oncology·Deniz Guven KarakurtEmin Sami Arisoy
May 4, 2010·The Journal of Pediatrics·Elisabeth E AddersonJames M Hoffman
May 25, 2016·International Journal of Antimicrobial Agents·Konstantinos Z VardakasMatthew E Falagas
Mar 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paula D RobinsonLillian Sung
May 2, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas LehrnbecherLillian Sung
Dec 17, 2011·The Pediatric Infectious Disease Journal·Arif ManjiLillian Sung
Nov 12, 2010·The Cochrane Database of Systematic Reviews·Mical PaulLeonard Leibovici
Dec 18, 2019·Pediatrics International : Official Journal of the Japan Pediatric Society·Shoji SaitoKazuo Sakashita
Oct 6, 2007·Scandinavian Journal of Infectious Diseases·Niklas StabellClaus Klingenberg
Dec 6, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Arif ManjiLillian Sung
Mar 22, 2018·Frontiers in Pediatrics·Saber JanMaria Gutierrez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.